[go: up one dir, main page]

DK116687D0 - Farmaceutisk praeparat indeholdende aenovantroneae - Google Patents

Farmaceutisk praeparat indeholdende aenovantroneae

Info

Publication number
DK116687D0
DK116687D0 DK116687A DK116687A DK116687D0 DK 116687 D0 DK116687 D0 DK 116687D0 DK 116687 A DK116687 A DK 116687A DK 116687 A DK116687 A DK 116687A DK 116687 D0 DK116687 D0 DK 116687D0
Authority
DK
Denmark
Prior art keywords
aenovantroneae
pharmaceutical preparation
preparation containing
novantrone
pharmaceutical formulations
Prior art date
Application number
DK116687A
Other languages
English (en)
Other versions
DK116687A (da
DK166754B1 (da
Inventor
Pradeep V Niphadkar
Narendra R Desai
Paul N Jones
Kieran G Mooney
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of DK116687D0 publication Critical patent/DK116687D0/da
Publication of DK116687A publication Critical patent/DK116687A/da
Application granted granted Critical
Publication of DK166754B1 publication Critical patent/DK166754B1/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
DK116687A 1986-03-07 1987-03-06 Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid DK166754B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83724386A 1986-03-07 1986-03-07
US83724386 1986-03-07

Publications (3)

Publication Number Publication Date
DK116687D0 true DK116687D0 (da) 1987-03-06
DK116687A DK116687A (da) 1987-09-08
DK166754B1 DK166754B1 (da) 1993-07-12

Family

ID=25273922

Family Applications (1)

Application Number Title Priority Date Filing Date
DK116687A DK166754B1 (da) 1986-03-07 1987-03-06 Stabilt, injicerbart praeparat indeholdende 1,4-dihydroxy-5,8-bis-oe2-(2-hydroxyethylamino)-ethylaminoaa-anthraquinon, dihydrochlorid

Country Status (21)

Country Link
EP (1) EP0236822B1 (da)
JP (1) JPH0717500B2 (da)
KR (1) KR900002030B1 (da)
AT (1) ATE59290T1 (da)
AU (1) AU593330B2 (da)
CA (1) CA1283607C (da)
DE (1) DE3766984D1 (da)
DK (1) DK166754B1 (da)
ES (1) ES2033247T3 (da)
FI (1) FI84977C (da)
GR (1) GR3001503T3 (da)
HK (1) HK63991A (da)
HU (1) HU199286B (da)
IE (1) IE60025B1 (da)
IL (1) IL81681A (da)
NO (1) NO173635C (da)
NZ (1) NZ219454A (da)
PH (1) PH22808A (da)
PT (1) PT84398B (da)
SG (1) SG45292G (da)
ZA (1) ZA871652B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE59409088D1 (de) * 1994-10-04 2000-02-24 Lohmann Rudolf Lomapharm Lösungen von Anthrachinonen zur parenteralen Applikation
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
KR20130132496A (ko) 2010-12-09 2013-12-04 마루이시세이야쿠가부시키가이샤 아세트아미노펜의 안정화제
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
ATE48942T1 (de) * 1984-02-27 1990-01-15 American Cyanamid Co Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

Also Published As

Publication number Publication date
HK63991A (en) 1991-08-23
FI870994A0 (fi) 1987-03-06
JPS62265220A (ja) 1987-11-18
ATE59290T1 (de) 1991-01-15
FI84977B (fi) 1991-11-15
NO870950L (no) 1987-09-08
AU6977387A (en) 1987-09-10
FI84977C (fi) 1992-02-25
KR870008581A (ko) 1987-10-19
NO173635B (no) 1993-10-04
SG45292G (en) 1992-06-12
FI870994A (fi) 1987-09-08
CA1283607C (en) 1991-04-30
DK116687A (da) 1987-09-08
ES2033247T3 (es) 1993-03-16
HUT47020A (en) 1989-01-30
JPH0717500B2 (ja) 1995-03-01
IE60025B1 (en) 1994-05-18
IL81681A (en) 1991-01-31
GR3001503T3 (en) 1992-11-23
DE3766984D1 (de) 1991-02-07
NZ219454A (en) 1989-04-26
PH22808A (en) 1988-12-27
PT84398A (en) 1987-04-01
EP0236822A2 (en) 1987-09-16
KR900002030B1 (ko) 1990-03-31
DK166754B1 (da) 1993-07-12
NO870950D0 (no) 1987-03-06
EP0236822B1 (en) 1990-12-27
AU593330B2 (en) 1990-02-08
PT84398B (pt) 1989-10-04
NO173635C (no) 1994-01-12
HU199286B (en) 1990-02-28
IE870569L (en) 1987-09-07
IL81681A0 (en) 1987-09-16
EP0236822A3 (en) 1989-01-11
ZA871652B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
SE8505112D0 (sv) Novel pharmacological compounds
DK203787D0 (da) Praeparat til nasal administrering
SE8801813D0 (sv) Pharmaceutical composition
DK149988D0 (da) Stabile farmaceutiske praeparater
FI871918A (fi) Komposition och foerfarande foer att foerhindra mikrobvaext.
NO870212L (no) Fremgangsmaate for fremstilling av stabile nikorandilpreparater.
SE8404065D0 (sv) Novel biologically active compounds
NO862587D0 (no) Fremgangsmaate for fremstilling av en injiserbar opploesning inneholdende et antitumorantracyklin-glykosid.
IT1211967B (it) Composizione farmaceutica contenente ranitidina
SE8600658D0 (sv) Novel composition of matter
DE3685182D1 (de) Nicarbazin enthaltende vormischungszusammensetzungen.
MX9203642A (es) Compuestos substituidos del acido 1,3,4,9-tetrahidropirano (3,4-b)-indol-1-acetico y composiciones farmaceuticas que los contienen.
DK116687D0 (da) Farmaceutisk praeparat indeholdende aenovantroneae
FR2598617B1 (fr) Composition pharmaceutique
IT8621112A0 (it) Derivati dell'acido tiazolidin-4-carbossilico adattivita' farmaceutica.
MX11584A (es) Composiciones farmaceuticas
DE3762800D1 (de) Benzhydrylthiomethan-derivate enthaltende therapeutische zusammensetzungen.
DE3669656D1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
IT8847657A0 (it) Procedimento per la preparazione di derivati stilbenici contenenti gruppi triazinile
IT1216814B (it) Composizioni farmaceutiche
DK530788D0 (da) Anvendelse af praeparater til desinfektion af afstoebninger
DK382688D0 (da) Anti-anxiogeniske sammensaetninger indeholdende dioxopiperidin derivater
DK501788A (da) Anvendelse af visse 6-mercaptopuriner til fremstilling af laegemidler
ATE51150T1 (de) Azanaphthalene enthaltende arzneimittelzusammensetzungen.
NO890992D0 (no) Fremstilling av bis(amin-holdige) benzendioler.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PUP Patent expired